Optic atrophy following treatment with diiodohydroxyquin.
D001623:Betamethasone / Q000627:therapeutic use; D002675:Child, Preschool; D003092:Colitis / Q000150:complications; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D006471:Gastrointestinal Hemorrhage / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007019:Hypoproteinemia / Q000188:drug therapy / Q000209:etiology; D004103:Iodoquinol / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced* / Q000188:drug therapy; D011736:Pyridoxine / Q000627:therapeutic use; D012002:Rectal Diseases / Q000188:drug therapy / Q000209:etiology; D013831:Thiamine / Q000627:therapeutic use
D004103:Iodoquinol; D001623:Betamethasone; D011736:Pyridoxine; D006854:Hydrocortisone; D013831:Thiamine